MAT

2c50_25e0

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 0 Give a dose too small to treat disease, only to see what the drug does in the body Phase 2 A few hundred randomized patients chosen with strict eligibility rules Phase 3 Compare the drug with other treatments while continuing to monitor side effects Phase 4 Monitor long-term effects after the drug is already being prescribed Phase 1 Find the safe dosage range and the earliest side effects MAT

2c50_8377

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 2 A few hundred randomized patients chosen with strict eligibility rules Phase 4 Patients who are already taking the approved drug Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit Phase 1 Healthy volunteers, or terminally ill volunteers when healthy people should avoid the drug Phase 3 Thousands of patients who have the condition the drug is meant to treat MAT

2c50_60e4

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit Phase 4 Monitor long-term effects after the drug is already being prescribed Phase 2 A few hundred randomized patients chosen with strict eligibility rules Phase 1 Healthy volunteers, or terminally ill volunteers when healthy people should avoid the drug Phase 3 Compare the drug with other treatments while continuing to monitor side effects MAT

2c50_7544

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 2 Test whether the drug is effective against the disease and record its side effects Phase 3 Compare the drug with other treatments while continuing to monitor side effects Phase 4 Patients who are already taking the approved drug Phase 1 Find the safe dosage range and the earliest side effects Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit MAT

2c50_7918

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 3 Compare the drug with other treatments while continuing to monitor side effects Phase 2 Test whether the drug is effective against the disease and record its side effects Phase 0 Give a dose too small to treat disease, only to see what the drug does in the body Phase 1 Healthy volunteers, or terminally ill volunteers when healthy people should avoid the drug Phase 4 Monitor long-term effects after the drug is already being prescribed MAT

2c50_681b

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 2 A few hundred randomized patients chosen with strict eligibility rules Phase 0 Give a dose too small to treat disease, only to see what the drug does in the body Phase 4 Monitor long-term effects after the drug is already being prescribed Phase 3 Thousands of patients who have the condition the drug is meant to treat Phase 1 Find the safe dosage range and the earliest side effects MAT

2c50_2e40

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 0 Give a dose too small to treat disease, only to see what the drug does in the body Phase 3 Thousands of patients who have the condition the drug is meant to treat Phase 2 A few hundred randomized patients chosen with strict eligibility rules Phase 1 Healthy volunteers, or terminally ill volunteers when healthy people should avoid the drug Phase 4 Patients who are already taking the approved drug MAT

2c50_5fa1

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 1 Find the safe dosage range and the earliest side effects Phase 4 Monitor long-term effects after the drug is already being prescribed Phase 3 Compare the drug with other treatments while continuing to monitor side effects Phase 0 Give a dose too small to treat disease, only to see what the drug does in the body Phase 2 Test whether the drug is effective against the disease and record its side effects MAT

2c50_dd2d

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 1 Find the safe dosage range and the earliest side effects Phase 3 Compare the drug with other treatments while continuing to monitor side effects Phase 2 A few hundred randomized patients chosen with strict eligibility rules Phase 0 Give a dose too small to treat disease, only to see what the drug does in the body Phase 4 Monitor long-term effects after the drug is already being prescribed MAT

2c50_f021

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 2 Test whether the drug is effective against the disease and record its side effects Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit Phase 1 Find the safe dosage range and the earliest side effects Phase 3 Thousands of patients who have the condition the drug is meant to treat Phase 4 Patients who are already taking the approved drug MAT

2c50_6f25

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 1 Healthy volunteers, or terminally ill volunteers when healthy people should avoid the drug Phase 2 Test whether the drug is effective against the disease and record its side effects Phase 4 Patients who are already taking the approved drug Phase 3 Compare the drug with other treatments while continuing to monitor side effects Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit MAT

2c50_494f

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit Phase 2 Test whether the drug is effective against the disease and record its side effects Phase 1 Healthy volunteers, or terminally ill volunteers when healthy people should avoid the drug Phase 4 Monitor long-term effects after the drug is already being prescribed Phase 3 Thousands of patients who have the condition the drug is meant to treat MAT

2c50_c8e8

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 2 A few hundred randomized patients chosen with strict eligibility rules Phase 4 Patients who are already taking the approved drug Phase 3 Thousands of patients who have the condition the drug is meant to treat Phase 1 Find the safe dosage range and the earliest side effects Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit MAT

2c50_dd90

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit Phase 2 Test whether the drug is effective against the disease and record its side effects Phase 3 Thousands of patients who have the condition the drug is meant to treat Phase 4 Patients who are already taking the approved drug Phase 1 Healthy volunteers, or terminally ill volunteers when healthy people should avoid the drug MAT

2c50_9fba

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 4 Patients who are already taking the approved drug Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit Phase 1 Find the safe dosage range and the earliest side effects Phase 3 Compare the drug with other treatments while continuing to monitor side effects Phase 2 Test whether the drug is effective against the disease and record its side effects MAT

2c50_6b46

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 4 Patients who are already taking the approved drug Phase 3 Compare the drug with other treatments while continuing to monitor side effects Phase 2 A few hundred randomized patients chosen with strict eligibility rules Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit Phase 1 Find the safe dosage range and the earliest side effects MAT

2c50_9930

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 2 A few hundred randomized patients chosen with strict eligibility rules Phase 0 Give a dose too small to treat disease, only to see what the drug does in the body Phase 3 Compare the drug with other treatments while continuing to monitor side effects Phase 1 Healthy volunteers, or terminally ill volunteers when healthy people should avoid the drug Phase 4 Monitor long-term effects after the drug is already being prescribed MAT

2c50_138e

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 3 Compare the drug with other treatments while continuing to monitor side effects Phase 4 Patients who are already taking the approved drug Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit Phase 2 Test whether the drug is effective against the disease and record its side effects Phase 1 Healthy volunteers, or terminally ill volunteers when healthy people should avoid the drug MAT

2c50_1670

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit Phase 1 Find the safe dosage range and the earliest side effects Phase 2 Test whether the drug is effective against the disease and record its side effects Phase 4 Monitor long-term effects after the drug is already being prescribed Phase 3 Thousands of patients who have the condition the drug is meant to treat MAT

2c50_04c5

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 3 Thousands of patients who have the condition the drug is meant to treat Phase 0 Give a dose too small to treat disease, only to see what the drug does in the body Phase 4 Patients who are already taking the approved drug Phase 1 Find the safe dosage range and the earliest side effects Phase 2 A few hundred randomized patients chosen with strict eligibility rules MAT

2c50_8d51

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 2 Test whether the drug is effective against the disease and record its side effects Phase 1 Healthy volunteers, or terminally ill volunteers when healthy people should avoid the drug Phase 4 Monitor long-term effects after the drug is already being prescribed Phase 3 Compare the drug with other treatments while continuing to monitor side effects Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit MAT

2c50_95c2

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 1 Find the safe dosage range and the earliest side effects Phase 2 A few hundred randomized patients chosen with strict eligibility rules Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit Phase 3 Thousands of patients who have the condition the drug is meant to treat Phase 4 Patients who are already taking the approved drug MAT

2c50_8ea4

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 4 Patients who are already taking the approved drug Phase 0 Give a dose too small to treat disease, only to see what the drug does in the body Phase 3 Thousands of patients who have the condition the drug is meant to treat Phase 1 Healthy volunteers, or terminally ill volunteers when healthy people should avoid the drug Phase 2 A few hundred randomized patients chosen with strict eligibility rules MAT

2c50_c01c

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 4 Monitor long-term effects after the drug is already being prescribed Phase 1 Find the safe dosage range and the earliest side effects Phase 0 Give a dose too small to treat disease, only to see what the drug does in the body Phase 2 Test whether the drug is effective against the disease and record its side effects Phase 3 Compare the drug with other treatments while continuing to monitor side effects MAT

2c50_1d48

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit Phase 3 Compare the drug with other treatments while continuing to monitor side effects Phase 2 A few hundred randomized patients chosen with strict eligibility rules Phase 4 Patients who are already taking the approved drug Phase 1 Healthy volunteers, or terminally ill volunteers when healthy people should avoid the drug MAT

2c50_e7fd

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit Phase 4 Monitor long-term effects after the drug is already being prescribed Phase 2 A few hundred randomized patients chosen with strict eligibility rules Phase 3 Thousands of patients who have the condition the drug is meant to treat Phase 1 Healthy volunteers, or terminally ill volunteers when healthy people should avoid the drug MAT

2c50_dd1f

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 2 A few hundred randomized patients chosen with strict eligibility rules Phase 3 Thousands of patients who have the condition the drug is meant to treat Phase 1 Healthy volunteers, or terminally ill volunteers when healthy people should avoid the drug Phase 0 Give a dose too small to treat disease, only to see what the drug does in the body Phase 4 Monitor long-term effects after the drug is already being prescribed MAT

2c50_3a84

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 3 Compare the drug with other treatments while continuing to monitor side effects Phase 1 Healthy volunteers, or terminally ill volunteers when healthy people should avoid the drug Phase 0 Give a dose too small to treat disease, only to see what the drug does in the body Phase 2 A few hundred randomized patients chosen with strict eligibility rules Phase 4 Monitor long-term effects after the drug is already being prescribed MAT

2c50_c315

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 2 Test whether the drug is effective against the disease and record its side effects Phase 4 Patients who are already taking the approved drug Phase 0 Give a dose too small to treat disease, only to see what the drug does in the body Phase 1 Find the safe dosage range and the earliest side effects Phase 3 Compare the drug with other treatments while continuing to monitor side effects MAT

2c50_2bed

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 2 A few hundred randomized patients chosen with strict eligibility rules Phase 4 Patients who are already taking the approved drug Phase 0 Give a dose too small to treat disease, only to see what the drug does in the body Phase 3 Compare the drug with other treatments while continuing to monitor side effects Phase 1 Healthy volunteers, or terminally ill volunteers when healthy people should avoid the drug MAT

2c50_6ff3

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 1 Find the safe dosage range and the earliest side effects Phase 3 Compare the drug with other treatments while continuing to monitor side effects Phase 2 A few hundred randomized patients chosen with strict eligibility rules Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit Phase 4 Monitor long-term effects after the drug is already being prescribed MAT

2c50_4c79

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit Phase 4 Patients who are already taking the approved drug Phase 3 Compare the drug with other treatments while continuing to monitor side effects Phase 1 Find the safe dosage range and the earliest side effects Phase 2 A few hundred randomized patients chosen with strict eligibility rules MAT

2c50_782b

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 0 Give a dose too small to treat disease, only to see what the drug does in the body Phase 2 A few hundred randomized patients chosen with strict eligibility rules Phase 3 Compare the drug with other treatments while continuing to monitor side effects Phase 4 Monitor long-term effects after the drug is already being prescribed Phase 1 Healthy volunteers, or terminally ill volunteers when healthy people should avoid the drug MAT

2c50_b33a

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 1 Find the safe dosage range and the earliest side effects Phase 3 Compare the drug with other treatments while continuing to monitor side effects Phase 0 Give a dose too small to treat disease, only to see what the drug does in the body Phase 4 Patients who are already taking the approved drug Phase 2 Test whether the drug is effective against the disease and record its side effects MAT

2c50_51c6

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 2 Test whether the drug is effective against the disease and record its side effects Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit Phase 4 Patients who are already taking the approved drug Phase 3 Compare the drug with other treatments while continuing to monitor side effects Phase 1 Healthy volunteers, or terminally ill volunteers when healthy people should avoid the drug MAT

2c50_b0fc

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 1 Healthy volunteers, or terminally ill volunteers when healthy people should avoid the drug Phase 4 Patients who are already taking the approved drug Phase 3 Compare the drug with other treatments while continuing to monitor side effects Phase 2 Test whether the drug is effective against the disease and record its side effects Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit MAT

2c50_6418

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 3 Thousands of patients who have the condition the drug is meant to treat Phase 1 Find the safe dosage range and the earliest side effects Phase 2 A few hundred randomized patients chosen with strict eligibility rules Phase 0 Give a dose too small to treat disease, only to see what the drug does in the body Phase 4 Patients who are already taking the approved drug MAT

2c50_d343

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 3 Thousands of patients who have the condition the drug is meant to treat Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit Phase 4 Monitor long-term effects after the drug is already being prescribed Phase 1 Find the safe dosage range and the earliest side effects Phase 2 Test whether the drug is effective against the disease and record its side effects MAT

2c50_1268

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 3 Thousands of patients who have the condition the drug is meant to treat Phase 0 Give a dose too small to treat disease, only to see what the drug does in the body Phase 1 Find the safe dosage range and the earliest side effects Phase 4 Monitor long-term effects after the drug is already being prescribed Phase 2 A few hundred randomized patients chosen with strict eligibility rules MAT

2c50_aec7

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 1 Healthy volunteers, or terminally ill volunteers when healthy people should avoid the drug Phase 4 Monitor long-term effects after the drug is already being prescribed Phase 2 A few hundred randomized patients chosen with strict eligibility rules Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit Phase 3 Compare the drug with other treatments while continuing to monitor side effects MAT

2c50_884c

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 1 Find the safe dosage range and the earliest side effects Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit Phase 4 Monitor long-term effects after the drug is already being prescribed Phase 3 Thousands of patients who have the condition the drug is meant to treat Phase 2 A few hundred randomized patients chosen with strict eligibility rules MAT

2c50_4040

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 3 Thousands of patients who have the condition the drug is meant to treat Phase 2 Test whether the drug is effective against the disease and record its side effects Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit Phase 4 Monitor long-term effects after the drug is already being prescribed Phase 1 Healthy volunteers, or terminally ill volunteers when healthy people should avoid the drug MAT

2c50_a536

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 4 Patients who are already taking the approved drug Phase 2 A few hundred randomized patients chosen with strict eligibility rules Phase 3 Compare the drug with other treatments while continuing to monitor side effects Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit Phase 1 Find the safe dosage range and the earliest side effects MAT

2c50_1016

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 1 Find the safe dosage range and the earliest side effects Phase 2 A few hundred randomized patients chosen with strict eligibility rules Phase 4 Monitor long-term effects after the drug is already being prescribed Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit Phase 3 Compare the drug with other treatments while continuing to monitor side effects MAT

2c50_030d

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit Phase 1 Find the safe dosage range and the earliest side effects Phase 2 Test whether the drug is effective against the disease and record its side effects Phase 3 Compare the drug with other treatments while continuing to monitor side effects Phase 4 Patients who are already taking the approved drug MAT

2c50_eed5

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 2 Test whether the drug is effective against the disease and record its side effects Phase 1 Find the safe dosage range and the earliest side effects Phase 4 Monitor long-term effects after the drug is already being prescribed Phase 3 Compare the drug with other treatments while continuing to monitor side effects Phase 0 Give a dose too small to treat disease, only to see what the drug does in the body MAT

2c50_de39

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit Phase 4 Monitor long-term effects after the drug is already being prescribed Phase 2 Test whether the drug is effective against the disease and record its side effects Phase 3 Thousands of patients who have the condition the drug is meant to treat Phase 1 Find the safe dosage range and the earliest side effects MAT

2c50_cc52

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit Phase 1 Find the safe dosage range and the earliest side effects Phase 4 Monitor long-term effects after the drug is already being prescribed Phase 3 Compare the drug with other treatments while continuing to monitor side effects Phase 2 Test whether the drug is effective against the disease and record its side effects MAT

2c50_8a8c

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 0 Give a dose too small to treat disease, only to see what the drug does in the body Phase 2 A few hundred randomized patients chosen with strict eligibility rules Phase 3 Compare the drug with other treatments while continuing to monitor side effects Phase 4 Patients who are already taking the approved drug Phase 1 Find the safe dosage range and the earliest side effects MAT

2c50_abf1

Match each clinical-trial phase to the correct description.

Note: Each choice will be used exactly once.

Phase 2 A few hundred randomized patients chosen with strict eligibility rules Phase 3 Compare the drug with other treatments while continuing to monitor side effects Phase 1 Find the safe dosage range and the earliest side effects Phase 0 Altruistic volunteers who accept an invasive study that offers no treatment benefit Phase 4 Monitor long-term effects after the drug is already being prescribed